ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 677815 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 677815; 2) Community: the network communities that were significantly associated with the response to NSC 677815; 3) Molecule: the relationships between components within communities and NSC 677815; 4) MDR: the compounds that were significantly associated with the NSC 677815.

NSC Compound Enrichment Correlation
NSC 654509 Pirarubicin HCl 0.00628187335688596 -0.067220825
NSC 626874 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-, hydrochloride 0.00628187335688605 0.43161228
NSC 638635 Propyl-1-aminium, 3-[3,5-bis(phenylmethylene)-4-oxo- piperidin-1-yl]-3-oxo-N,N,N-trimethyl-, bromide 0.00628187335688605 0.54903569
NSC 681646 Camptothecin Derivative 0.00628187335688605 -0.085564225
NSC 692348 Null 0.00628187335688605 0.062569805
NSC 735373 Bis{(5,6-dihydro-5,11-diketo-2,3-dimethoxy-11H-indeno[1,2-c] isoquinoline)-6-propylamino}propane Bis(trifluoroacetate) 0.00628187335688605 0.29002606
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.00628187335688605 0.19722302
NSC 744063 Null 0.00628187335688605 0.37689385
NSC 87868 2-Phenylethyl isothiocyanate 0.00628187335688605 0.3768888
NSC 622294 Null 0.00701295499506013 0.27046145
Total:47  Current:7    [First] [Prev] [Next] [Last]